| Autor: |
Hernández-Negrín H; Medical University of Villa Clara, Santa Clara, Cuba., Roque-Dapresa Y; Medical University of Villa Clara, Santa Clara, Cuba., Martínez-Morales O; Institución Prestadora de Servicios de Salud 'Asistir Salud', Bogotá, Colombia., Mederos-Portal A; Arnaldo Milián Castro University Hospital, Medical University of Villa Clara, Santa Clara, Cuba. |
| Jazyk: |
angličtina |
| Zdroj: |
MEDICC review [MEDICC Rev] 2021 Apr; Vol. 23 (2), pp. 69. Date of Electronic Publication: 2021 Apr 30. |
| DOI: |
10.37757/MR2021.V23.N2.12 |
| Abstrakt: |
Autoimmune diseases are not always recognized as urgent health issues, despite a worldwide prevalence of 4%-5%. Most estimates come from high-income countries, as low- and middle-income countries face more issues of under-reporting. Despite this and the lack of recognition under current reporting practices, the role these diseases play in mortality must be acknowledged. In particular, considering multiple causes of death as opposed to a single cause of death results in a 1.5-4.2-fold increase in deaths classified as relating to autoimmune diseases, evidence of their share in overall mortality burden, a factor important for patient care and healthcare policy decision making. However, formulating such policies and programs for timely, appropriate diagnoses and care is stymied in low- and middle-income countries by the shortage of methodologically sound studies on mortality from systemic autoimmune diseases. This limitation exacerbates inequalities and health gaps among patients in different countries and localities. Multiple cause-of-death methodology has been validated for research on other diseases and demonstrates the mortality burden of these illnesses in countries where traditional methodological approaches, primarily based on prospective cohort studies, are not feasible. Studying mortality from systemic autoimmune diseases by analyzing multiple causes of death with data from national mortality registries is a low-cost alternative to traditional mortality analysis. The objective of this paper is to demonstrate and defend the usefulness of this approach to estimate mortality burden. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
